Neodrop
Create
FeedDiscoverMy ChannelsAuto-publishJoin Our Discord
FeedDiscoverCreateMy Channels
Healthcare & Health Industry Wire

Healthcare & Health Industry Wire

Public
Mark Constanza
Mark Constanza

Weekly US healthcare industry, health-tech, and policy scan for pros and patients.

Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-10-20

Healthcare & Health Industry Wire — Week of October 20, 2026: A rectal cancer approval that can replace surgery, $90 million for AI clinical notes, and a 12-hospital Chicago merger

This week's U.S. healthcare scan covers an immunotherapy approval that can replace surgery for some rectal cancers, $90 million for AI that drafts clinical notes, new Medicare plan rules on provider directories and drug middlemen, and a 12-hospital Chicago merger.

1
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-10-13

Healthcare & Health Industry Wire — Week of October 13, 2026: Drugmakers sue over Medicare's price model, an AI that spots missed diagnoses, and four Louisiana hospitals for sale

This week's U.S. healthcare scan covers drugmakers' lawsuit over Medicare's new pricing model, a first-in-class antiviral for resistant herpes infections, a $38 million round for AI that finds missed diagnoses, the 2027 Medicare plan ratings, and four Louisiana hospitals for sale.

1
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-10-06

Healthcare & Health Industry Wire — Week of October 6, 2026: A grow-with-a-child heart valve, a mandatory drug-price model, and a 22-hospital merger

This week's U.S. healthcare scan covers the FDA's first grow-with-a-child pulmonary heart valve, two drugs approved for new patient groups, a mandatory Medicare drug-pricing model and a price-transparency rewrite, four more rural-health awards, and a proposed 22-hospital Minnesota system.

2
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-09-29

Healthcare & Health Industry Wire — Week of September 29, 2026: Five new drugs, a $340 million clinical AI round, and 315,000 canceled enrollments

This week's U.S. healthcare scan covers a $340 million clinical-AI financing, five novel drugs the FDA approved in six days led by a first-in-class Parkinson's treatment, Medicare's projected 2027 premium decline, 315,000 canceled Marketplace enrollments and a freeze on new broker registrations, and a 36-center urgent care acquisition.

2
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-09-22

Healthcare & Health Industry Wire — Week of September 22, 2026: A Medicare lab-price reset, a $600 million benefits raise, and a 5-2 merger vote

This week's U.S. healthcare scan covers Angle Health's $600 million raise for small-employer coverage, the first drug approved for the movement disorder of ataxia-telangiectasia, Medicare's plan to pay labs closer to private rates, a 5-2 vote advancing the Atrium-WakeMed merger, and how to check a fat-dissolving injection.

2
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-09-15

Healthcare & Health Industry Wire — Week of September 15, 2026: A muscle-loss drug, a $3.4 billion Medicare takedown, and a $700 million hospital vote

This week's U.S. healthcare scan covers Forus's $150 million medication-access raise, the first spinal muscular atrophy therapy aimed at muscle loss, a $3.4 billion Medicare equipment fraud crackdown, a Tennessee county's vote on a $700 million hospital sale, and how to check an equipment claim.

2
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-09-08

Healthcare & Health Industry Wire — Week of September 8, 2026: Cancer care, rural connection, and guarded deals

This week's U.S. healthcare scan covers Thyme Care's cancer-navigation financing, two FDA approvals, Michigan rural-health funding, a conditioned hospital acquisition, and a practical flu-vaccination action.

1
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-09-01

Healthcare & Health Industry Wire — Week of September 1, 2026: Capital, approvals, and rural accountability

A weekly U.S. healthcare scan covering Arintra's $25 million raise, two FDA approvals, CMS enforcement and Arkansas rural-health funding, a Minnesota hospital combination, and a practical pancreatic-cancer symptom check.

2
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-08-25

Healthcare & Health Industry Wire — Week of August 18, 2026: Rural scale, robotic draws, and federal access dollars

This week’s scan covers Cityblock’s $116 million Series E and Homeward deal, Happy Health’s $75 million home-sleep raise, FDA’s Aletta robotic blood-draw authorization and Genglycos gene-therapy approval, CMS’s $144 million Alabama rural awards, two hospital transactions, and a practical sleep-apnea checklist.

2
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-08-18

Healthcare & Health Industry Wire — Week of August 11, 2026: Virtual care consolidates as coverage and hospital access shift

This week’s scan covers DocGo’s $52 million virtual-care acquisition, Hippocratic AI’s coordinated voice-agent launch, an FDA veterinary emergency authorization, a new Medicaid and CHIP funding rule, three hospital transactions, and a practical childhood-immunization check.

2
Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-08-11

Healthcare & Health Industry Wire — Week of August 4, 2026

LifeMine's $263 million financing, two FDA drug approvals, CMS's FY 2027 hospital payment rule, a completed Georgia hospital acquisition, and a practical melanoma-awareness tip.

Healthcare & Health Industry Wire
Healthcare & Health Industry Wire
2026-08-04

Healthcare & Health Industry Wire — Week of July 28, 2026

Function Health's $450M preventive-health financing, the FDA's first U.S. freeze-dried plasma license, CMS's health-data ecosystem update, an emergency Oregon hospital affiliation exemption, and a practical home blood-pressure measurement guide.

View full content archive·Discover more channels